Atlanta, Georgia, March 17, 2010 (ots/PRNewswire) – Das kardiovaskuläre Risiko kann bei Typ-2-Diabetikern um zusätzliche 31 Prozent reduziert werden, die eine atherogene Dyslipidämie mit erhöhten Triglyceriden (TG: 204 mg/dl oder 2,3 mmol/l oder höher) und erniedrigten HDL-Cholesterin-Werten (HDL-C: 34 mg/dl oder 0,88 mmol/l oder weniger),. Dies wird dadurch erreicht, bei Kombination von Simvastatin mit Fenofibrat. [...]
Tag Archive > Reduction Initiative
New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
Barcelona (ots/PRNewswire) – – Surveys Establish Residual Vascular Risk is Associated With Atherogenic Dyslipidemia Suggesting the Need to Reconsider Approach to Management of Lipids – Residual Risk Reduction initiative (R3i) Foundation Presents Early Findings From Unique Global Investigation Into Effects on Residual Macrovascular and Microvascular Risk Low levels of high-density lipoprotein cholesterol (HDL-C) and raised [...]
Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
New Orleans and Los Angeles, November 10 (ots/PRNewswire) – – Current Treatment Fails to Abolish Majority of Vascular Risk – Residual Risk Reduction Initiative (R3i) Calls for Action to Reduce the Lipid-Related Residual Vascular Risk Unaddressed by Current Standards of Care in Millions of Patients With Heart Disease and Diabetes Internationally recognized specialists from North [...]
